Eur J Pediatr Surg 2016; 26(01): 047-053
DOI: 10.1055/s-0035-1559886
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Effect of N-Acetylserotonin on Intestinal Recovery Following Intestinal Ischemia–Reperfusion Injury in a Rat

Yoav Ben Shahar
1   Department of Surgery, Carmel Medical Center, Haifa, Israel
3   Laboratory of Intestinal Adaptation and Recovery, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
*   The authors contributed equally to the article.
,
Igor Sukhotnik
2   Department of Pediatric Surgery, Bnai Zion Medical Center, Haifa, Israel
3   Laboratory of Intestinal Adaptation and Recovery, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
*   The authors contributed equally to the article.
,
Nir Bitterman
3   Laboratory of Intestinal Adaptation and Recovery, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
,
Yulia Pollak
3   Laboratory of Intestinal Adaptation and Recovery, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
,
Jacob Bejar
4   Department of Pathology, Bnai Zion Medical Center, Haifa, Israel
,
Dmitriy Chepurov
4   Department of Pathology, Bnai Zion Medical Center, Haifa, Israel
,
Arnold Coran
5   Section of Pediatric Surgery, C.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, Michigan, United States
,
Arie Bitterman
1   Department of Surgery, Carmel Medical Center, Haifa, Israel
› Author Affiliations
Further Information

Publication History

25 May 2015

22 June 2015

Publication Date:
17 September 2015 (online)

Abstract

ObjectiveN-acetylserotonin (NAS) is a naturally occurring chemical intermediate in the biosynthesis of melatonin. Extensive studies in various experimental models have established that treatment with NAS significantly protects heart and kidney injury from ischemia–reperfusion (IR). The purpose of the present study was to examine the effect of NAS on intestinal recovery and enterocyte turnover after intestinal IR injury in rats.

Methods Male Sprague–Dawley rats were divided into four experimental groups: (1) Sham rats underwent laparotomy, (2) sham–NAS rats underwent laparotomy and were treated with intraperitoneal (IP) NAS (20 mg/kg); (3) IR rats underwent occlusion of both superior mesenteric artery and portal vein for 30 minutes, followed by 48 hours of reperfusion, and (4) IR–NAS rats underwent IR and were treated with IP NAS (20 mg/kg) immediately before abdominal closure. Intestinal structural changes, Park injury score, enterocyte proliferation, and enterocyte apoptosis were determined 24 hours following IR. The expression of Bax, Bcl-2, p-ERK, and caspase-3 in the intestinal mucosa was determined using real-time polymerase chain reaction, Western blot, and immunohistochemistry. A nonparametric Kruskal–Wallis analysis of variance test was used for statistical analysis with p less than 0.05 considered statistically significant.

Results Treatment with NAS resulted in a significant increase in mucosal weight in jejunum and ileum, villus height in the ileum, and crypt depth in jejunum and ileum compared with IR animals. IR–NAS rats also had a significantly proliferation rates as well as a lower apoptotic index in jejunum and ileum which was accompanied by higher Bcl-2 levels compared with IR animals.

Conclusions Treatment with NAS prevents gut mucosal damage and inhibits programmed cell death following intestinal IR in a rat.

 
  • References

  • 1 Granger DN, Höllwarth ME, Parks DA. Ischemia-reperfusion injury: role of oxygen-derived free radicals. Acta Physiol Scand Suppl 1986; 548: 47-63
  • 2 Schoenberg MH, Poch B, Younes M , et al. Involvement of neutrophils in postischaemic damage to the small intestine. Gut 1991; 32 (8) 905-912
  • 3 Yamamoto S, Tanabe M, Wakabayashi G, Shimazu M, Matsumoto K, Kitajima M. The role of tumor necrosis factor-alpha and interleukin-1beta in ischemia-reperfusion injury of the rat small intestine. J Surg Res 2001; 99 (1) 134-141
  • 4 Haglund U, Bergqvist D. Intestinal ischemia — the basics. Langenbecks Arch Surg 1999; 384 (3) 233-238
  • 5 Khanna A, Rossman J, Caty MG, Fung HL. Beneficial effects of intraluminal nitroglycerin in intestinal ischemia-reperfusion injury in rats. J Surg Res 2003; 114 (1) 15-24
  • 6 Tosini G, Ye K, Iuvone PM. N-acetylserotonin: neuroprotection, neurogenesis, and the sleepy brain. Neuroscientist 2012; 18 (6) 645-653
  • 7 Yu S, Zheng J, Jiang Z , et al. Protective effect of N-acetylserotonin against acute hepatic ischemia-reperfusion injury in mice. Int J Mol Sci 2013; 14 (9) 17680-17693
  • 8 Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993; 15 (3) 532-534 , 536–537
  • 9 Park PO, Haglund U, Bulkley GB, Fält K. The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery 1990; 107 (5) 574-580
  • 10 Adkison D, Höllwarth ME, Benoit JN, Parks DA, McCord JM, Granger DN. Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol Scand Suppl 1986; 548: 101-107
  • 11 Bhogal RH, Curbishley SM, Weston CJ, Adams DH, Afford SC. Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation. Liver Transpl 2010; 16 (11) 1303-1313
  • 12 Bohlen HG. Intestinal tissue PO2 and microvascular responses during glucose exposure. Am J Physiol 1980; 238 (2) H164-H171
  • 13 Tunc T, Oter S, Güven A , et al. Protective effect of sulfhydryl-containing antioxidants against ischemia/reperfusion injury of prepubertal rat intestine. J Gastroenterol Hepatol 2009; 24 (4) 681-687
  • 14 Chen Z, Chua CC, Gao J , et al. Prevention of ischemia/reperfusion-induced cardiac apoptosis and injury by melatonin is independent of glutathione peroxdiase 1. J Pineal Res 2009; 46 (2) 235-241
  • 15 Li Z, Nickkholgh A, Yi X , et al. Melatonin protects kidney grafts from ischemia/reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. J Pineal Res 2009; 46 (4) 365-372
  • 16 Mathes AM. Hepatoprotective actions of melatonin: possible mediation by melatonin receptors. World J Gastroenterol 2010; 16 (48) 6087-6097
  • 17 Muñoz-Casares FC, Padillo FJ, Briceño J , et al. Melatonin reduces apoptosis and necrosis induced by ischemia/reperfusion injury of the pancreas. J Pineal Res 2006; 40 (3) 195-203
  • 18 Petrosillo G, Colantuono G, Moro N , et al. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol 2009; 297 (4) H1487-H1493
  • 19 Fagali N, Catalá A. The antioxidant behaviour of melatonin and structural analogues during lipid peroxidation depends not only on their functional groups but also on the assay system. Biochem Biophys Res Commun 2012; 423 (4) 873-877
  • 20 Guajardo MH, Terrasa AM, Catalá A. Protective effect of indoleamines on in vitro ascorbate-Fe2+ dependent lipid peroxidation of rod outer segment membranes of bovine retina. J Pineal Res 2003; 35 (4) 276-282
  • 21 Oxenkrug G, Ratner R. N-acetylserotonin and aging-associated cognitive impairment and depression. Aging Dis 2012; 3 (4) 330-338
  • 22 Sukhotnik I, Shehadeh N, Mogilner J , et al. Beneficial effects of oral insulin on intestinal recovery following ischemia-reperfusion injury in rat. J Surg Res 2005; 128 (1) 108-113
  • 23 Zhou H, Wang J, Jiang J , et al. N-acetyl-serotonin offers neuroprotection through inhibiting mitochondrial death pathways and autophagic activation in experimental models of ischemic injury. J Neurosci 2014; 34 (8) 2967-2978